[Role of multi-drug resistance in genito-urinary tumors].
Theyer
G
G
Service d'Urologie, Wilhelminenspital, Vienna, Autriche.
Hamilton
G
G
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002352:Carrier Proteins / Q000096:biosynthesis / Q000302:isolation & purification / Q000502:physiology*; D004351:Drug Resistance; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000302:isolation & purification / Q000502:physiology*; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000503:physiopathology
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D002352:Carrier Proteins; D008562:Membrane Glycoproteins
Rôle de la résistance multi-drogues dans les tumeurs génito-urinaries.